These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 9438181)

  • 1. Adeno-associated viral vectors: background and technical aspects.
    Snoeck HW; Tao W; Klotman ME
    Exp Nephrol; 1997; 5(6):514-20. PubMed ID: 9438181
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gene transfer by adeno-associated virus vectors into the central nervous system.
    Xiao X; Li J; McCown TJ; Samulski RJ
    Exp Neurol; 1997 Mar; 144(1):113-24. PubMed ID: 9126160
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adeno-associated virus vector-mediated gene delivery to the vasculature and kidney.
    Kapturczak MH; Chen S; Agarwal A
    Acta Biochim Pol; 2005; 52(2):293-9. PubMed ID: 15940344
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adeno-associated viral vectors for gene transfer and gene therapy.
    Büeler H
    Biol Chem; 1999 Jun; 380(6):613-22. PubMed ID: 10430026
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Successful interference with cellular immune responses to immunogenic proteins encoded by recombinant viral vectors.
    Sarukhan A; Camugli S; Gjata B; von Boehmer H; Danos O; Jooss K
    J Virol; 2001 Jan; 75(1):269-77. PubMed ID: 11119597
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chromosomal latency and expression at map unit 96 of a wild-type plus adeno-associated virus (AAV)/Neo vector and identification of p81, a new AAV transcriptional promoter.
    Hermonat PL; Santin AD; De Greve J; De Rijcke M; Bishop BM; Han L; Mane M; Kokorina N
    J Hum Virol; 1999; 2(6):359-68. PubMed ID: 10774553
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recombinant adeno-associated viral vectors as therapeutic agents to treat neurological disorders.
    Mandel RJ; Manfredsson FP; Foust KD; Rising A; Reimsnider S; Nash K; Burger C
    Mol Ther; 2006 Mar; 13(3):463-83. PubMed ID: 16412695
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recombinant adeno-associated virus derived vectors (rAAV2) efficiently transduce ovarian and hepatocellular carcinoma cells--implications for cancer gene therapy.
    Małecki M; Swoboda P; Pachecka J
    Acta Pol Pharm; 2009; 66(1):93-9. PubMed ID: 19226976
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adeno-associated virus-mediated gene delivery.
    Snyder RO
    J Gene Med; 1999; 1(3):166-75. PubMed ID: 10738565
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High-titer recombinant adeno-associated virus production utilizing a recombinant herpes simplex virus type I vector expressing AAV-2 Rep and Cap.
    Conway JE; Rhys CM; Zolotukhin I; Zolotukhin S; Muzyczka N; Hayward GS; Byrne BJ
    Gene Ther; 1999 Jun; 6(6):986-93. PubMed ID: 10455400
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transduction of ovarian cancer cells: a recombinant adeno-associated viral vector compared to an adenoviral vector.
    Vermeij J; Zeinoun Z; Neyns B; Teugels E; Bourgain C; De Grève J
    Br J Cancer; 2001 Nov; 85(10):1592-9. PubMed ID: 11720450
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Can genes transduced by adeno-associated virus vectors elicit or evade an immune response?
    Wang CH; Liu DW; Tsao YP; Xiao X; Chen SL
    Arch Virol; 2004 Jan; 149(1):1-15. PubMed ID: 14689272
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Viral vectors for gene therapy.
    Robbins PD; Ghivizzani SC
    Pharmacol Ther; 1998 Oct; 80(1):35-47. PubMed ID: 9804053
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Site-specific integration of a transgene mediated by a hybrid adenovirus/adeno-associated virus vector using the Cre/loxP-expression-switching system.
    Ueno T; Matsumura H; Tanaka K; Iwasaki T; Ueno M; Fujinaga K; Asada K; Kato I
    Biochem Biophys Res Commun; 2000 Jul; 273(2):473-8. PubMed ID: 10873630
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Generation of recombinant adeno-associated virus vectors by a complete adenovirus-mediated approach.
    Zhang X; Li CY
    Mol Ther; 2001 May; 3(5 Pt 1):787-92. PubMed ID: 11356083
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hepatic gene therapy using adeno-associated virus vectors.
    Patijn GA; Kay MA
    Semin Liver Dis; 1999; 19(1):61-9. PubMed ID: 10349684
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Trends in development of self-complementary adeno-associated virus vector].
    Lü Y; Wang Q; Xiao W; Diao Y; Xu R
    Sheng Wu Gong Cheng Xue Bao; 2009 May; 25(5):658-64. PubMed ID: 19670632
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adeno-associated virus 2-mediated transduction and erythroid lineage-restricted long-term expression of the human beta-globin gene in hematopoietic cells from homozygous beta-thalassemic mice.
    Tan M; Qing K; Zhou S; Yoder MC; Srivastava A
    Mol Ther; 2001 Jun; 3(6):940-6. PubMed ID: 11407908
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preclinical gene therapy studies for hemophilia using adeno-associated virus (AAV) vectors.
    Couto LB
    Semin Thromb Hemost; 2004 Apr; 30(2):161-71. PubMed ID: 15118928
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recombinant AAV vectors containing the foot and mouth disease virus 2A sequence confer efficient bicistronic gene expression in cultured cells and rat substantia nigra neurons.
    Furler S; Paterna JC; Weibel M; Büeler H
    Gene Ther; 2001 Jun; 8(11):864-73. PubMed ID: 11423934
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.